Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Brickell enters $25mm financing agreement with NovaQuest

Executive Summary

NovaQuest Capital Management committed up to $25mm in near-term research and development funding to Brickell Biotech Inc. following the closing of Brickell's concurrent reverse merger with Vical Inc., which will hold a 40% stake in the combined company.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Preliminary
Deal Type
  • Financing
    • Other
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register